| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/GLIA.23937 |
| P698 | PubMed publication ID | 33245604 |
| P50 | author | Hannes Kaddatz | Q103015211 |
| Markus Kipp | Q88161810 | ||
| P2093 | author name string | Michael Müller | |
| Paul van der Valk | |||
| Sandra Amor | |||
| Christoph Schmitz | |||
| Martin Stangel | |||
| Brigitte Müller-Hilke | |||
| Viktoria Gudi | |||
| Stefan Gingele | |||
| Sarah Joost | |||
| Uta Chrzanowski | |||
| Jiangshan Zhan | |||
| Julia Frenz | |||
| Theresa Greiner | |||
| Emily Santrau | |||
| Julia Nedelcu | |||
| P2860 | cites work | Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis | Q93191325 |
| NIH Image to ImageJ: 25 years of image analysis | Q23319322 | ||
| Visualization of cytolytic T cell differentiation and granule exocytosis with T cells from mice expressing active fluorescent granzyme B | Q27312334 | ||
| CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis | Q27320766 | ||
| Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis | Q28144207 | ||
| Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses | Q28240137 | ||
| The Resource Identification Initiative: a cultural shift in publishing | Q28604129 | ||
| Inefficient clearance of myelin debris by microglia impairs remyelinating processes | Q30636334 | ||
| Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. | Q33874526 | ||
| Activated T-cells inhibit neurogenesis by releasing granzyme B: rescue by Kv1.3 blockers | Q33885724 | ||
| Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions | Q34280654 | ||
| Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial | Q34675482 | ||
| Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. | Q34710256 | ||
| Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis | Q35656408 | ||
| Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice | Q35675218 | ||
| Microglial recruitment, activation, and proliferation in response to primary demyelination | Q35757235 | ||
| IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination | Q36142154 | ||
| Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells | Q36259730 | ||
| Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction | Q36368672 | ||
| Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. | Q36403556 | ||
| Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis. | Q36765165 | ||
| Th17 Cells and autoimmune encephalomyelitis (EAE/MS). | Q37143735 | ||
| The relation between inflammation and neurodegeneration in multiple sclerosis brains. | Q37181308 | ||
| Axons are injured by antigen-specific CD8(+) T cells through a MHC class I- and granzyme B-dependent mechanism | Q37210942 | ||
| Astrocytes modulate the polarization of CD4+ T cells to Th1 cells. | Q37525226 | ||
| Interferon β for secondary progressive multiple sclerosis: a systematic review | Q38041082 | ||
| Progressive multiple sclerosis: pathology and pathogenesis | Q38046113 | ||
| T cell apoptosis and induction of Foxp3+ regulatory T cells underlie the therapeutic efficacy of CD4 blockade in experimental autoimmune encephalomyelitis | Q38457848 | ||
| Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients. | Q38720773 | ||
| Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions | Q38964699 | ||
| Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis | Q39647474 | ||
| Role of cytotoxic protease granzyme-b in neuronal degeneration during human stroke. | Q39658123 | ||
| Signal 3 tolerant CD8 T cells degranulate in response to antigen but lack granzyme B to mediate cytolysis | Q40370346 | ||
| Chronic progressive multiple sclerosis - pathogenesis of neurodegeneration and therapeutic strategies | Q41136886 | ||
| Regulatory T cells promote myelin regeneration in the central nervous system. | Q41757690 | ||
| The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination | Q41958515 | ||
| Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes | Q41959017 | ||
| MHC class II exacerbates demyelination in vivo independently of T cells | Q42080688 | ||
| Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model | Q47118503 | ||
| Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. | Q47596113 | ||
| Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression | Q47912566 | ||
| Efficient central nervous system remyelination requires T cells | Q47933086 | ||
| Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice | Q48132771 | ||
| Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice | Q48292000 | ||
| Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice | Q48300700 | ||
| The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model | Q48338954 | ||
| Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. | Q48427400 | ||
| Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier | Q48487727 | ||
| Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS. | Q48607199 | ||
| The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion | Q48646930 | ||
| Cortical demyelination and diffuse white matter injury in multiple sclerosis. | Q48726181 | ||
| TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination | Q48744723 | ||
| Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI. | Q48756437 | ||
| Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions | Q48791086 | ||
| Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain | Q48945835 | ||
| Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secon | Q50654674 | ||
| Lysophosphatidyl choline-induced focal demyelination in the rabbit corpus callosum. Light-microscopic observations. | Q50946181 | ||
| The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. | Q52072205 | ||
| The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. | Q55449054 | ||
| Multicontrast MRI of remyelination in the central nervous system | Q57187694 | ||
| Biochemically altered myelin triggers autoimmune demyelination | Q58452226 | ||
| Blood-brain barrier permeability during Cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases | Q68951748 | ||
| Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions | Q72773066 | ||
| Multiple sclerosis☆Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages | Q72785304 | ||
| Vulnerability of human neurons to T cell-mediated cytotoxicity | Q73552887 | ||
| Continuous cuprizone intoxication allows active experimental autoimmune encephalomyelitis induction in C57BL/6 mice | Q90258569 | ||
| Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity | Q90413465 | ||
| CD8 T-cell Recruitment Into the Central Nervous System of Cuprizone-Fed Mice: Relevance to Modeling the Etiology of Multiple Sclerosis | Q90638165 | ||
| Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis | Q90946953 | ||
| Laquinimod Supports Remyelination in Non-Supportive Environments | Q91094524 | ||
| Laquinimod ameliorates secondary brain inflammation | Q91297371 | ||
| High Speed Ventral Plane Videography as a Convenient Tool to Quantify Motor Deficits during Pre-Clinical Experimental Autoimmune Encephalomyelitis | Q91325712 | ||
| B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis | Q91529739 | ||
| The Cuprizone Model: Dos and Do Nots | Q91541153 | ||
| Delayed Demyelination and Impaired Remyelination in Aged Mice in the Cuprizone Model | Q91925113 | ||
| Progressive multiple sclerosis: from pathophysiology to therapeutic strategies | Q92535375 | ||
| Animal Weight Is an Important Variable for Reliable Cuprizone-Induced Demyelination | Q92774817 | ||
| Behavioural phenotypes in the cuprizone model of central nervous system demyelination | Q92818398 | ||
| P921 | main subject | cuprizone | Q27262585 |
| P577 | publication date | 2020-11-27 | |
| P1433 | published in | Glia | Q15716658 |
| P1476 | title | Cuprizone-induced demyelination triggers a CD8-pronounced T cell recruitment |
Search more.